Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-07

Clinical Trial Update: A Pilot Study of TRV130 for the Treatment of Fracture Pain [Phase 2]

View source ↗

Summary

Phase 2 pilot study of TRV130 for fracture pain was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRV130 (oliceridine)

Snippet

Sponsor: Trevena Inc. | Conditions: Pain | Phase 2 | Status: TERMINATED | Results posted: 2020-09-07